Gan & Lee Pharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -12.64% vs 2.54% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -40.81% vs 51.47% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "878.10",
          "val2": "1,005.10",
          "chgp": "-12.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "186.30",
          "val2": "88.90",
          "chgp": "109.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "6.70",
          "val2": "1.80",
          "chgp": "272.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "192.50",
          "val2": "325.20",
          "chgp": "-40.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "212.20%",
          "val2": "8.10%",
          "chgp": "20.41%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 34.05% vs 15.90% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 86.04% vs 80.69% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,040.40",
          "val2": "3,014.20",
          "chgp": "34.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,065.30",
          "val2": "554.60",
          "chgp": "92.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "0.50",
          "chgp": "240.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "134.80",
          "val2": "150.90",
          "chgp": "-10.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,143.60",
          "val2": "614.70",
          "chgp": "86.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "188.10%",
          "val2": "98.00%",
          "chgp": "9.01%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

878.10

1,005.10

-12.64%

Operating Profit (PBDIT) excl Other Income

186.30

88.90

109.56%

Interest

0.00

0.00

Exceptional Items

6.70

1.80

272.22%

Consolidate Net Profit

192.50

325.20

-40.81%

Operating Profit Margin (Excl OI)

212.20%

8.10%

20.41%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -12.64% vs 2.54% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -40.81% vs 51.47% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

4,040.40

3,014.20

34.05%

Operating Profit (PBDIT) excl Other Income

1,065.30

554.60

92.08%

Interest

1.70

0.50

240.00%

Exceptional Items

134.80

150.90

-10.67%

Consolidate Net Profit

1,143.60

614.70

86.04%

Operating Profit Margin (Excl OI)

188.10%

98.00%

9.01%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 34.05% vs 15.90% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 86.04% vs 80.69% in Dec 2024

All Annual Results